NCT04460131 - Soluble ST2 and Cardiovascular Outcome | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Cardiovascular Disease

Interventions

DIAGNOSTIC_TEST

soluble ST2

Serum sST2 was measured on a monoclonal electrochemiluminescence immunoassay. Samples were exposed to two freeze cycles before analysed. Samples were exposed to two thawfreeze cycles before analysed.

Trial Locations (1)

210029

RECRUITING

The first affiliated hospital of nanjing medical university, Nanjing